Page last updated: 2024-08-23

raloxifene hydrochloride and Ovarian Cysts

raloxifene hydrochloride has been researched along with Ovarian Cysts in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azam, F; Chennathukuzhi, VM; Harris, HA; Huselton, C; Jelinsky, SA; Mekonnen, B; Negahban, A; Patel, VS; Schelling, SH; Winneker, RC; Zhang, X	1
Cecchini, RS; Costantino, JP; Cronin, WM; Ford, LG; Runowicz, CD; Vogel, VG; Wickerham, DL; Wolmark, N	1
Busacca, M; Chiodo, I; Infantino, M; Matrone, R; Somigliana, E; Viganò, P; Vignali, M	1

Reviews

1 review(s) available for raloxifene hydrochloride and Ovarian Cysts

Article	Year
Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertility and sterility, 2002, Volume: 78, Issue:4 Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Endometriosis; Enzyme Inhibitors; Female; Humans; Immunity, Cellular; MEDLINE; Ovarian Cysts; Ovarian Diseases; Ovarian Neoplasms; Postmenopause; Raloxifene Hydrochloride; Rectal Diseases; Selective Estrogen Receptor Modulators; Vaginal Diseases	2002

Article

Year

Endometriosis: novel etiopathogenetic concepts and clinical perspectives.

Fertility and sterility, 2002, Volume: 78, Issue:4

Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Endometriosis; Enzyme Inhibitors; Female; Humans; Immunity, Cellular; MEDLINE; Ovarian Cysts; Ovarian Diseases; Ovarian Neoplasms; Postmenopause; Raloxifene Hydrochloride; Rectal Diseases; Selective Estrogen Receptor Modulators; Vaginal Diseases

2002

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Ovarian Cysts

Article	Year
Development of an early biomarker for the ovarian liability of selective estrogen receptor modulators in rats. The Journal of steroid biochemistry and molecular biology, 2008, Volume: 112, Issue:1-3 Topics: Animals; Biomarkers; Brain; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Female; Naphthalenes; Ovarian Cysts; Ovary; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators; Steroid 17-alpha-Hydroxylase; Up-Regulation	2008
Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR). American journal of obstetrics and gynecology, 2011, Volume: 205, Issue:6 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Estrogen Antagonists; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Leiomyoma; Middle Aged; Ovarian Cysts; Polyps; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms; Vaginal Discharge	2011

Article

Year

Development of an early biomarker for the ovarian liability of selective estrogen receptor modulators in rats.

The Journal of steroid biochemistry and molecular biology, 2008, Volume: 112, Issue:1-3

Topics: Animals; Biomarkers; Brain; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Female; Naphthalenes; Ovarian Cysts; Ovary; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators; Steroid 17-alpha-Hydroxylase; Up-Regulation

2008

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).

American journal of obstetrics and gynecology, 2011, Volume: 205, Issue:6

Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Estrogen Antagonists; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Leiomyoma; Middle Aged; Ovarian Cysts; Polyps; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms; Vaginal Discharge

2011